Text & Content Analysis
This page analyzes how a selected category, entity, or narrative frame appears in recent news coverage within the specified time window. Metrics and breakdowns are derived from the active article corpus.
Explore by Category
Corpus KPIs
Entity
ai promises
Articles
1
From
2026-07-19 23:41:59+00
To
2026-07-19 23:41:59+00
Range
2026-06-21 16:45:55.216723+00 →
2026-07-21 16:45:55.216723+00
Who’s being talked about
Top Entities
| Entity | Label | Mentions | Actions |
|---|---|---|---|
| 200 million | MONEY | 1 | 📊 🔍 🧲 |
| 45 billion | MONEY | 1 | 📊 🔍 🧲 |
| accord plasma | PERSON | 1 | 📊 🔍 🧲 |
| acg | ORG | 1 | 📊 🔍 🧲 |
| ai promises | ORG | 1 | 📊 🔍 🧲 |
| alnylam | ORG | 1 | 📊 🔍 🧲 |
| apac | ORG | 1 | 📊 🔍 🧲 |
| asia | LOC | 1 | 📊 🔍 🧲 |
| asian | NORP | 1 | 📊 🔍 🧲 |
| astrazeneca | ORG | 1 | 📊 🔍 🧲 |
| atlanta astrazeneca invests | ORG | 1 | 📊 🔍 🧲 |
| belén garijo steps | PERSON | 1 | 📊 🔍 🧲 |
| bio asia | FAC | 1 | 📊 🔍 🧲 |
| bio asiataiwan | ORG | 1 | 📊 🔍 🧲 |
| bio asiataiwan 2026 | LOC | 1 | 📊 🔍 🧲 |
| build advanced manufacturing facility | ORG | 1 | 📊 🔍 🧲 |
| clinical trials go next the frontier that wont | ORG | 1 | 📊 🔍 🧲 |
| cmc | ORG | 1 | 📊 🔍 🧲 |
| employees facing fertility challenges consider leaving their jobs biomed x | ORG | 1 | 📊 🔍 🧲 |
| esco | ORG | 1 | 📊 🔍 🧲 |
| expanding us medicine production news | ORG | 1 | 📊 🔍 🧲 |
| gmp | ORG | 1 | 📊 🔍 🧲 |
| intas group | ORG | 1 | 📊 🔍 🧲 |
| iso class | ORG | 1 | 📊 🔍 🧲 |
| isoiec | ORG | 1 | 📊 🔍 🧲 |
Articles included
Top entities
Top sources
Top narrative frames
| Pub Date | Category | Domain | Title | Analyze | Author | Sent | Score |
|---|---|---|---|---|---|---|---|
| 2026-07-19 23:41:59+00 | Science |
|
Creative Life Science Showcases Regenerative Medicine Manufacturing Capabilities at BIO Asia–Taiwan 2026 | Analyze | biopharmaapac.com | 😐 neutral | 0.1442 |